Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Language
Publication year range
1.
Ann N Y Acad Sci ; 816: 250-62, 1997 Jun 17.
Article in English | MEDLINE | ID: mdl-9238275

ABSTRACT

Spinal bone density of 41 girls with diet-induced amenorrhea (DA) was compared with that of the density of 22 subjects with premature ovarian failure (POF) of comparable age. The Z score values, as well as the estradiol levels, were not significantly different in the two groups. The duration of amenorrhea was significantly correlated to bone mass density in the DA population, especially when considering subjects with amenorrhea that had lasted longer than 20 months. A similar correlation between weight loss and BMD was evident. Although estradiol concentrations did not seem to be correlated to the Z score, FT3 and cortisol values exhibited, respectively, a negative and a positive correlation with spinal density. Cortisol seemed to act precociously, whereas FT3 acted later than cortisol.


Subject(s)
Amenorrhea/etiology , Amenorrhea/physiopathology , Bone Density , Diet, Reducing/adverse effects , Adolescent , Adult , Amenorrhea/blood , Case-Control Studies , Female , Hormones/blood , Humans , Time Factors , Weight Loss
2.
Eur J Contracept Reprod Health Care ; 2(4): 253-8, 1997 Dec.
Article in English | MEDLINE | ID: mdl-9678082

ABSTRACT

The effects of steroidal hormones on sexual desire and motivation are a question still under debate. This paper reviews up-to-date knowledge regarding physiological imprinting and activation by endogenous hormones of central nervous system areas involved in libido during intrauterine life and puberty. The endocrine environment probably continues to play a role during fertile life and the postmenopausal period, but this effect is often overridden by psychological and social factors. The impairment of sexual interest during estrogen-progestin treatment is an infrequent but relevant side-effect whose possible underlying mechanisms are discussed. Both endocrine and psychorelational elements may interact. From the biological point of view, androgen and oxytocin level modification and loss of estrogen fluctuations have been considered, but also the history of hormone-related mood changes could be a risk factor. On the psychological side, both the profound repercussions of the contraceptive choice and consequent responsibility, as well as the high value attributed to sexual experience are probably facilitating elements in the loss of libido under treatment.


Subject(s)
Brain Chemistry/physiology , Gonadal Steroid Hormones/physiology , Libido/physiology , Brain Chemistry/drug effects , Contraceptives, Oral, Hormonal/pharmacology , Estrogen Replacement Therapy , Female , Humans , Imprinting, Psychological/physiology , Libido/drug effects , Male , Menopause/physiology , Puberty/physiology
SELECTION OF CITATIONS
SEARCH DETAIL